Saying its InterPharm Laboratories would not be financially successful, the world's third-largest biotechnology company plans to cease operating in the country by the end of the year, except for a small corporate development team. The once high-tech labs developed Serono's treatment for multiple sclerosis, Rebif.

Full Story:
Globes (Israel)

Related Summaries